KindlyMD, Inc. $NAKA Shares Purchased by Vanguard Group Inc.

Vanguard Group Inc. raised its holdings in shares of KindlyMD, Inc. (NASDAQ:NAKA) by 32,737.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,036,750 shares of the company’s stock after acquiring an additional 6,018,366 shares during the quarter. Vanguard Group Inc. owned approximately 100.24% of KindlyMD worth $150,557,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in the business. Rathbones Group PLC purchased a new position in KindlyMD in the second quarter valued at approximately $1,523,000. Geode Capital Management LLC boosted its stake in KindlyMD by 76.2% in the second quarter. Geode Capital Management LLC now owns 19,394 shares of the company’s stock valued at $484,000 after acquiring an additional 8,386 shares during the period. Osaic Holdings Inc. acquired a new position in KindlyMD during the 2nd quarter valued at about $215,000. Vontobel Holding Ltd. bought a new position in shares of KindlyMD in the third quarter worth $335,000. Finally, Almanack Investment Partners LLC. acquired a new stake in shares of KindlyMD in the third quarter valued at $1,377,000.

KindlyMD Trading Down 1.3%

Shares of NAKA opened at $0.25 on Wednesday. The firm’s 50 day moving average is $0.35 and its 200-day moving average is $1.46. KindlyMD, Inc. has a 12 month low of $0.23 and a 12 month high of $34.77. The stock has a market capitalization of $109.30 million, a PE ratio of -0.22 and a beta of 31.44.

Wall Street Analyst Weigh In

NAKA has been the topic of a number of recent research reports. B. Riley Financial lowered their target price on KindlyMD from $1.00 to $0.50 and set a “buy” rating on the stock in a research note on Monday, February 23rd. Weiss Ratings reiterated a “sell (e+)” rating on shares of KindlyMD in a research note on Monday, December 29th. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, KindlyMD presently has an average rating of “Hold” and an average price target of $4.25.

KindlyMD Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.